Amgen Inc.
CH ˙ SWX ˙ NL0000888691
SecurityCH:AMGN / Amgen Inc.
InstitutionBelpointe Asset Management LLC
Latest Disclosed Ownership6,447 shares
Latest Disclosed Value $ 2,268,618
Belpointe Asset Management LLC reports 4.93% decrease in ownership of AMGN / Amgen Inc.

On April 28, 2026 - Belpointe Asset Management LLC filed a 13F-HR form disclosing ownership of 6,447 shares of Amgen Inc. (CH:AMGN) valued at $2,268,618 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 27, 2026 disclosing 6,781 shares of Amgen Inc.. This represents a change in shares of -4.93% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-28 2026-03-31 13F AMGEN COM 031162100 6,447 -334 -4.93 2,269 2.21 0.0828
2026-01-27 2025-12-31 13F AMGEN COM 031162100 6,781 390 6.10 2,220 23.07 0.0802
2025-11-03 2025-09-30 13F AMGEN COM 031162100 6,391 -173 -2.64 1,804 -1.58 0.0689
2025-07-22 2025-06-30 13F AMGEN COM 031162100 6,564 165 2.58 1,833 -8.08 0.0764
2025-05-20 2025-03-31 13F AMGEN COM 031162100 6,399 -3,361 -34.44 1,994 -38.83 0.1037
2025-02-13 2024-12-31 13F AMGEN COM 031162100 9,760 1,638 20.17 3,258 24.49 0.1963
2024-11-13 2024-09-30 13F AMGEN COM 031162100 8,122 1,846 29.41 2,617 33.45 0.1570
2024-08-02 2024-06-30 13F AMGEN COM 031162100 6,276 -422 -6.30 1,961 2.99 0.1368
2024-05-08 2024-03-31 13F AMGEN COM 031162100 6,698 -1,005 -13.05 1,905 -14.16 0.1426
2024-02-13 2023-12-31 13F AMGEN COM 031162100 7,703 -1,477 -16.09 2,219 -10.09 0.1949
2023-11-15 2023-09-30 13F AMGEN COM 031162100 9,180 1,644 21.82 2,467 47.46 0.2555
2023-08-15 2023-06-30 13F AMGEN COM 031162100 7,536 -1,724 -18.62 1,673 -25.25 0.1770
2023-05-15 2023-03-31 13F AMGEN COM 031162100 9,260 3,034 48.73 2,239 36.88 0.1209
2023-02-08 2022-12-31 13F AMGEN COM 031162100 6,226 256 4.29 1,635 21.56 0.0988
2022-11-14 2022-09-30 13F AMGEN COM 031162100 5,970 706 13.41 1,345 5.08 0.0909
2022-08-02 2022-06-30 13F AMGEN COM 031162100 5,264 -806 -13.28 1,280 -12.81 0.0858
2022-04-28 2022-03-31 13F AMGEN COM 031162100 6,070 638 11.75 1,468 20.13 0.0890
2022-02-15 2021-12-31 13F AMGEN COM 031162100 5,432 578 11.91 1,222 18.41 0.0762
2021-11-15 2021-09-30 13F AMGEN COM 031162100 4,854 -717 -12.87 1,032 -24.01 0.0704
2021-08-09 2021-06-30 13F AMGEN COM 031162100 5,571 1,278 29.77 1,358 27.15 0.0977
2021-05-14 2021-03-31 13F AMGEN COM 031162100 4,293 -1,524 -26.20 1,068 -20.18 0.0914
2021-02-16 2020-12-31 13F AMGEN COM 031162100 5,817 844 16.97 1,338 5.85 0.1201
2020-11-13 2020-09-30 13F/A-1 AMGEN COM 031162100 4,973 -201 -3.88 1,264 3.61 0.1407
2020-11-13 2020-09-30 13F AMGEN COM 031162100 5,574 1,130
2020-07-20 2020-06-30 13F AMGEN COM 031162100 5,174 -400 -7.18 1,220 7.96 0.1580
2020-07-20 2020-03-31 13F AMGEN COM 031162100 5,574 -2,105 -27.41 1,130 -38.98 0.1979
2020-02-18 2019-12-31 13F AMGEN COM 031162100 7,679 3,079 66.93 1,852 108.09 0.2350
2020-01-16 2019-09-30 13F AMGEN COM 031162100 4,600 450 10.84 890 16.34 0.1440
2019-11-22 2019-06-30 13F AMGEN COM 031162100 4,150 -2,796 -40.25 765 -42.05 0.1505
2019-06-11 2019-03-31 13F AMGEN COM 031162100 6,946 1,096 18.74 1,320 15.89 0.2578
2019-03-06 2018-12-31 13F AMGEN COM 031162100 5,850 2,541 76.79 1,139 66.03 0.2887
2018-11-23 2018-09-30 13F AMGEN COM 031162100 3,309 1,212 57.80 686 77.26 0.1085
2018-08-06 2018-06-30 13F AMGEN COM 031162100 2,097 -746 -26.24 387 -20.21 0.1081
2018-08-06 2018-03-31 13F AMGEN COM 031162100 2,843 441 18.36 485 16.03 0.1414
2018-02-14 2017-12-31 13F AMGEN COM 031162100 2,402 -101 -4.04 418 -10.49 0.0916
2017-11-16 2017-09-30 13F AMGEN COM 031162100 2,503 2,503 467 0.1093
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.